Digital agency

New patient site for Allergan and Belkyra

2018/11/14

Allergan is a global pharmaceutical company with operations in over 100 countries. Allergan develops, produces and sells medicines and other products in areas such as eye care, urology, central nervous system and medical aesthetics. Perhaps the most well-known is the Allergan for its drug Botox.

We are happy to work together with Allergan to offer patients clear and good patient communication in the field of medical aesthetics. Patients have the right to receive quality-assured and correct information before, during and after their treatment.

Together with Allergan, we have had the privilege of launching a new patient site for the drug Belkyra, a prescription drug used to treat and reduce double chin.

We have done design, front end and back end development as well as written copy and got the site LIF-approved. The result was a modern site with clear information and clean design and where the focus has been on user-friendliness and clarity. The site is fully responsive.

At Belkyrapatient.se , the patient finds, among other things, a browser-friendly e-book version of the patient brochure, questions and answers as well as clear and illustrative information about the treatment with Belkyra.

A patient site helps the patient to absorb information about the drug and contributes to increased patient safety – belkyrapatient.se is a clear example of this.

See the nice result here: Belkyrapatient.se

Related News

New Drivkraft launched for EY

We at Add Health Media's Digital Agency have been working for many years with EY - a world-leading global company in auditing, accounting, tax and…

Digital agency

2018/07/10